rs11726

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_004385.5(VCAN):​c.*1429A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.553 in 151,892 control chromosomes in the GnomAD database, including 23,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.55 ( 23495 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

VCAN
NM_004385.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:3

Conservation

PhyloP100: 2.63

Publications

6 publications found
Variant links:
Genes affected
VCAN (HGNC:2464): (versican) This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
VCAN Gene-Disease associations (from GenCC):
  • Wagner disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 5-83581863-A-G is Benign according to our data. Variant chr5-83581863-A-G is described in ClinVar as Benign. ClinVar VariationId is 354492.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.657 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004385.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VCAN
NM_004385.5
MANE Select
c.*1429A>G
3_prime_UTR
Exon 15 of 15NP_004376.2
VCAN
NM_001164097.2
c.*1429A>G
3_prime_UTR
Exon 14 of 14NP_001157569.1P13611-2
VCAN
NM_001164098.2
c.*1429A>G
3_prime_UTR
Exon 14 of 14NP_001157570.1P13611-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VCAN
ENST00000265077.8
TSL:1 MANE Select
c.*1429A>G
3_prime_UTR
Exon 15 of 15ENSP00000265077.3P13611-1
VCAN
ENST00000343200.9
TSL:1
c.*1429A>G
3_prime_UTR
Exon 14 of 14ENSP00000340062.5P13611-2
VCAN
ENST00000342785.8
TSL:1
c.*1429A>G
3_prime_UTR
Exon 14 of 14ENSP00000342768.4P13611-3

Frequencies

GnomAD3 genomes
AF:
0.553
AC:
83973
AN:
151774
Hom.:
23484
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.479
Gnomad AMI
AF:
0.850
Gnomad AMR
AF:
0.667
Gnomad ASJ
AF:
0.606
Gnomad EAS
AF:
0.613
Gnomad SAS
AF:
0.576
Gnomad FIN
AF:
0.530
Gnomad MID
AF:
0.563
Gnomad NFE
AF:
0.563
Gnomad OTH
AF:
0.584
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.553
AC:
84020
AN:
151892
Hom.:
23495
Cov.:
32
AF XY:
0.554
AC XY:
41152
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.479
AC:
19843
AN:
41442
American (AMR)
AF:
0.667
AC:
10185
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.606
AC:
2102
AN:
3470
East Asian (EAS)
AF:
0.613
AC:
3158
AN:
5154
South Asian (SAS)
AF:
0.574
AC:
2765
AN:
4816
European-Finnish (FIN)
AF:
0.530
AC:
5580
AN:
10526
Middle Eastern (MID)
AF:
0.541
AC:
159
AN:
294
European-Non Finnish (NFE)
AF:
0.563
AC:
38214
AN:
67910
Other (OTH)
AF:
0.588
AC:
1239
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1934
3869
5803
7738
9672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
722
1444
2166
2888
3610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.537
Hom.:
2782
Bravo
AF:
0.560
Asia WGS
AF:
0.610
AC:
2114
AN:
3474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Wagner disease (2)
-
-
1
Vitreoretinopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
8.7
DANN
Benign
0.64
PhyloP100
2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11726; hg19: chr5-82877682; COSMIC: COSV54101269; COSMIC: COSV54101269; API